EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome
Open Access
- 30 April 2024
- journal article
- research article
- Published by Elsevier in Clinical Neurophysiology
- Vol. 163, 132-142
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian studyJournal of Neurology, 2023
- Toxicities following CAR-T therapy for hematological malignanciesCancer Treatment Reviews, 2022
- Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)Annals of Oncology, 2022
- Side-effect management of chimeric antigen receptor (CAR) T-cell therapyAnnals of Oncology, 2021
- Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T ImmunotherapiesCell, 2020
- Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapyAmerican Journal of Hematology, 2019
- ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsTransplantation and Cellular Therapy, 2019
- A revised glossary of terms most commonly used by clinical electroencephalographers and updated proposal for the report format of the EEG findings. Revision 2017Clinical Neurophysiology Practice, 2017
- Cognitive correlates of interictal epileptiform discharges in adult patients with epilepsy in ChinaEpilepsy & Behavior, 2013
- Cerebral palsy: Interictal epileptiform discharges and cognitive impairmentClinical Neurology and Neurosurgery, 2007